VigiEye watches EMA, the European Commission, 18 EU national medicines agencies, MHRA and FDA for regulatory, pharmacovigilance and clinical-trial changes. Every change in your scope is summarised, linked to its official source and kept in a dated monitoring record you can export for audits, sponsor qualifications and inspections.
Enterprise licences for pharma companies and CROs · Pro from €249 per user per month for individual RA and PV professionals
Inspectors and auditors ask the same question: how do you know when the legislation changes, and what did you do about it? VigiEye answers the first half, with evidence.
Marketing authorisation holders need documented regulatory intelligence for pharmacovigilance, labelling, quality and market access. One watch for RA, PV and QA, filtered by market and subject, with a dated record for inspections and partner audits.
Sponsors audit how you keep up with clinical-trial, GCP and safety-reporting rules in every country you run studies. Show them a source-linked watch across EU and US authorities, and the monitoring record behind it.
Every item is time-stamped when VigiEye captures it and linked to the official source. Export the monitoring record for any period and scope, and file it with your regulatory-surveillance SOP.
National agencies publish in their own languages, on their own websites, with no common feed. VigiEye brings them together and tells you what changed and why it matters.
EMA, the European Commission and HMA, 18 national competent authorities, MHRA, FDA and Health Canada. Pick the markets you operate in.
Slice by subject: signal management, PSUR/PBRER, labelling & SmPC, GVP inspections, clinical trials (CTR), falsified medicines, and more.
Each update gets a plain-language summary of what changed and an impact flag, clearly labelled as AI, with the official document one click away.
A weekday e-mail briefing with the new approvals, safety actions, guidelines and deadlines, plus a regulatory calendar of what is coming up.
Every item links to the official publication it came from. Links to anything other than an official source are filtered out.
Export a dated CSV of every change captured in your scope for any period: capture time, source date, authority, subject, impact and the official link.
Set it up once. VigiEye does the watching, summarising and prioritising continuously.
Select the markets and the subjects your SOP says you must watch.
VigiEye checks EMA, the European Commission, HMA, the national agencies, MHRA and FDA every two hours.
Each change gets a plain-language summary, effective date and impact rating, cited to source.
A daily briefing, a filtered workspace, and a monitoring record you can export for any period.
Every level of the European medicines landscape, mapped to a consistent country × subject grid.
EMA committee meetings, MDR/IVDR and HTA milestones, guideline and consultation deadlines, each linked to its official source. See the full calendar →
Individual plans start today. Company and enterprise licences come with onboarding to your surveillance procedure.
Tell us your markets and subjects, and we will set up a trial of your watch and its monitoring record.
Book a demo